Vericel Corp VCEL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
48.35UNCH (UNCH)
Volume
33,760,408
Close
48.35quote price arrow up+0.74 (+1.55%)
Volume
338,754
52 week range
30.18 - 53.05
Loading...
  • Open47.79
  • Day High48.53
  • Day Low47.09
  • Prev Close47.61
  • 52 Week High53.05
  • 52 Week High Date04/01/24
  • 52 Week Low30.18
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap2.35B
  • Shares Out48.60M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • YTD % Change35.78

KEY STATS

  • Open47.79
  • Day High48.53
  • Day Low47.09
  • Prev Close47.61
  • 52 Week High53.05
  • 52 Week High Date04/01/24
  • 52 Week Low30.18
  • 52 Week Low Date10/13/23
  • Market Cap2.35B
  • Shares Out48.60M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • YTD % Change35.78

RATIOS/PROFITABILITY

  • EPS (TTM)0.01
  • P/E (TTM)5,057.53
  • Fwd P/E (NTM)755.47
  • EBITDA (TTM)1.198M
  • ROE (TTM)0.21%
  • Revenue (TTM)207.78M
  • Gross Margin (TTM)69.50%
  • Net Margin (TTM)0.22%
  • Debt To Equity (MRQ)0.07%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vericel Corp

 

Profile

MORE
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone...
Robert Zerbe
Independent Chairman of the Board
Dominick Colangelo
President, Chief Executive Officer, Director
Michael Halpin
Chief Operating Officer
Joseph Mara
Chief Financial Officer
Address
64 Sidney St
Cambridge, MA
02139-4170
United States

Top Peers

SYMBOLLASTCHG%CHG
DCPH
Deciphera Pharmaceuticals Inc
25.46+0.01+0.04%
MOR
MorphoSys AG
19.00-0.34-1.76%
TWST
Twist Bioscience Corp
47.01+0.51+1.10%
RYTM
Rhythm Pharmaceuticals Inc
37.96-1.21-3.09%
TGTX
TG Therapeutics Inc
16.48-0.94-5.40%